A poptosis, or programmed cell death, regulates tissue development and homeostasis in multicellular organisms. Extrinsic or intrinsic death signals activate proapoptotic pathways, resulting in the activation of caspases and finally in cell death. An important event during the apoptosis process is the permeabilization of the outer mitochondrial membrane. Integrity of the outer mitochondrial membrane is regulated by the Bcl-2 protein family, which is divided into three groups: antiapoptotic members Bcl-2, Bcl-x L , and myeloid cell leukemia-1 (Mcl-1); proapoptotic multidomain members Bax and Bak; and proapoptotic BH3-only proteins. Mitochondrial activation is regulated by selective interactions of Bcl-2 proteins via their Bcl-2 homology (BH) domains. [1] [2] [3] [4] Expression of Mcl-1 has been found to be induced in cells at various stages of differentiation, in response to specific growth, differentiation, and survival factors. The importance of Mcl-1 during differentiation has been pointed out in Mcl-1 knockout mice, which die at an early stage of embryogenesis. 5 In conditional Mcl-1 knockout models, hematopoietic stem cells as well as early-stage B or T cells die due to apoptosis induction. 6, 7 Due to its antiapoptotic properties, Mcl-1 is a potential proto-oncogene. Mcl-1 transgenic mice show an increased incidence of B cell lymphomas. 8 In addition, enhanced expression of Mcl-1 is observed in a wide range of tumors, including hepatocellular carcinoma. 9, 10 To date, little is known about the role of Mcl-1 in nontransformed cells. Mcl-1 expression is indispensable for the survival of hematopoietic stem cells, early stage B and T cells, 6, 7 and macrophages. 11 We have recently shown that induction of Mcl-1 by hepatocyte growth factor protects primary human hepatocytes from CD95 (APO-1/Fas)-induced apoptosis. 12 This observation is in line with studies which have shown that Mcl-1 transgenic mice are rescued from acute liver failure induced by CD95 triggering. 13 Therefore, we assume that Mcl-1 is an important antiapoptotic factor for the liver.
In this study, we generated hepatocyte-specific Mcl-1 knockout mice. In the absence of Mcl-1, liver homeostasis is critically affected. Spontaneous induction of apoptosis is increased in Mcl-1 negative hepatocytes, resulting in profound liver damage and hepatic fibrosis. Furthermore, hepatocytes lacking Mcl-1 expression are more sensitive to proapoptotic stimuli. Therefore, we conclude that Mcl-1 is a central antiapoptotic factor for hepatocytes.
Materials and Methods

Generation of Conditional Mcl-1 Knockout Mice.
Mcl-1 flox/flox mice 7 were bred to heterozygous AlbuminCre mice 14 A scheme of the different genotypes can be found in Opferman et al. 7 All animals were bred at the animal facility of the University of Mainz, had free access to water and food under standard conditions with a 12-hour dark/light cycle, and received humane care. All experiments were done in accordance with German federal law and were approved by the Local Committee for Experimental Animal Research.
Animal Genotyping. For genotyping, ear biopsies were digested overnight at 56°C with proteinase K (Calbiochem, Schwalbach, Germany) in buffer containing 100 mM Tris-HCl pH 7.6, 50 mM ethylene diamine tetraacetic acid (EDTA) pH 8.0, 0.5% sodium dodecyl sulfate. Afterward, proteinase K was heatinactivated at 96°C for 3 minutes, and the solution was diluted with 10 volume of water. One L of the solution was used for polymerase chain reaction (PCR)-based genotyping. PCR was performed using the following primers: Mcl-1 flox: 5Ј-CT-GAGAGTTGTACCGGACAA-3Ј and 5Ј-GCAGT-ACAGGTTCAAGCCGATG-3Ј; Mcl-1 deleted  (⌬): 5Ј-CTGAGAGTTGTACCGGACAA-3Ј and   5Ј-ACGCTCTTTAAGTGTTTGGCC-3Ј; Cre: 5Ј-GCACTGATTTCGACCAGGTT-3Јand 5Ј-CCCGG-CAAAACAGGTAGTTA-3Ј; Actin (internal control  for Cre PCR): 5Ј-TGTTACCAACTGGGACGACA3Јand 5Ј-GACATGCAAGGAGTGCAAGA-3Ј . PCR was performed in a standard thermocycler and analyzed on 2% agarose gels.
Aminotransferase Levels. About 100 L of blood was collected from the tail vein. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured in the Institute of Clinical and Laboratory Medicine at the University Hospital Mainz by standard procedures.
Acute Liver Damage. Mice were injected intraperitonally with 0.5 mg/kg body weight of an anti-mouse CD95 monoclonal antibody (Jo2; BD Pharmingen, Heidelberg, Germany) 15 or with 25 mg/kg body weight concanavalin A (ConA, Sigma) into the tail vein. After the indicated time points, mice were sacrificed, blood was collected, and livers were shock-frozen in liquid nitrogen or transferred into 4% phosphate buffered saline (PBS)-buffered formalin (55 mM Na 2 HPO 4 , 12 mM NaH 2 PO 4 , 4% formalin, pH 7.4) until further analysis.
Isolation of Hepatocytes. Hepatocytes were isolated by a two-step perfusion technique. 16 Briefly, mice were anesthetized with 2.5% Avertin (2,2,2-tribromoethanol; Sigma) and livers were perfused in situ with about 100 mL of buffer I containing 140 mM NaCl, 7 mM KCl, and 10 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES) pH 7.4. Livers were then perfused with 50 mL of buffer II containing 70 mM NaCl, 7 mM KCl, 5 mM CaCl 2 , 100 mM HEPES pH 7.6, and 0.5 mg/mL collagenase (Serva, Heidelberg, Germany). Thereafter, livers were mechanically disrupted in buffer I, and cells were suspended and washed twice with Dulbecco's modified Eagle's medium (DMEM; Gibco, Karlsruhe, Germany).
Tissue Lysis and Western Blotting. About 20 mg of shock-frozen liver tissue were minced, transferred into ice-cold lysis buffer containing 20 mM Tris-HCl (pH 8.0), 5 mM EDTA, 0.5% Triton-X 100, and 1ϫ protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany), and incubated on ice for 15 minutes. Cell debris was removed by centrifugation (10,000g at 4°C). Protein concentration was determined by D c Protein Assay (BioRad, Munich, Germany), and equal amounts of protein were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Immunodetection was performed using the following primary antibodies: Mcl-1 (Rockland, Gilbertsville, PA), Bcl-x L (H-62; Santa Cruz Biotechnology, Heidelberg, Germany), Bak (BD Pharmingen), Bax (Cell Signaling Technology, Frankfurt, Germany), Bid (Cell Signaling Technology), and ␣-tubulin (Sigma). Peroxi-dase-conjugated species-specific secondary antibodies (Santa Cruz Biotechnology) were used at a dilution of 1:10,000. Bound antibody was visualized using chemiluminescent substrate (PerkinElmer, Zaventem, Belgium) and exposure to Fuji Medical X-Ray film. All western blots were performed for at least two male and two female mice at each age indicated.
Caspase Assay. Caspase-3 activity was measured as previously described. 17 DNA and RNA Isolation. For DNA isolation, about 20 mg of shock-frozen liver tissue were lysed overnight with proteinase K (see above). For isolation of total RNA, about 20 mg of shock-frozen liver tissue were homogenized in 1 mL TRI-Reagent (Sigma), and further isolated according to the manufacturer's instructions. RNA concentration was measured in a NanoDrop photometer (Peqlab, Erlangen, Germany), and 1 g of total RNA was subjected to reverse transcription using Oligo-dT primers. Isolated DNA and complementary DNA (cDNA) were used for PCR (see above) and real-time (RT) PCR approaches, respectively.
RT Quantitative PCR. Relative target messenger RNA (mRNA) expression was analyzed by RT-quantitative PCR using the QuantiTect SYBR Green PCR Kit and QuantiTect primers (Qiagen, Hilden, Germany) for murine Mcl-1, interleukin-6 (IL-6), tumor necrosis factor (TNF), collagen-1, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The relative increase in reporter fluorescent dye emission was monitored. The level of target mRNA, relative to GAPDH, was calculated using the formula: Relative target mRNA/GAPDH mRNA expression ϭ 1/2 ∧ [c t target -c t GAPDH ] * 100, where c t is defined as the number of the cycle in which emission exceeds threshold levels.
Histology and Immunohistochemistry. Liver specimens were fixed in 4% PBS-buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin as well as Sirius red using standard histological techniques. In addition, slides were immunostained for activated caspase-3 (rabbit polyclonal antibody, 1:300 dilution; Cell Signaling Technology) and Ki67 (monoclonal rabbit clone SP6, 1:100 dilution; NeoMarkers) using the Ventana Discovery automated staining system with an iView DAB kit (Ventana, Tucson, AZ), replacing the secondary antibody with a donkey anti-rabbit biotinylated antibody (Jackson 711-065-152, 1:80 dilution; Jackson ImmunoResearch). All sections were counterstained with hematoxylin. The whole section was evaluated for the number of positive hepatocytes, and pictures were taken from representative high-power fields (at 200ϫ magnification).
Detection of Cell Proliferation. Mice were exposed to 0.8 mg/mL bromodeoxyuridine (BrdU; Roche) in drinking water for 60 hours. Mice were sacrificed and livers were shock-frozen in liquid nitrogen. Tissue sections (5 m) were prepared and BrdU-positive cells were stained with the In Situ Cell Proliferation Kit (Roche) according to the manufacturer's instructions. Afterward, nuclei were counterstained with 2 g/mL 4Ј,6-diamidino-2-phenylindole (DAPI; Molecular Probes, Karlsruhe, Germany) for 15 minutes at room temperature. Sections were analyzed for fluorescein isothiocyanate (FITC) and DAPI staining with a fluorescence microscope using corresponding filters. From each mouse, two independent sections were stained and seven microscopic fields from each section were analyzed by counting FITCpositive and DAPI-positive nuclei.
Detection of Apoptosis. Mice were sacrificed and livers were shock-frozen in liquid nitrogen. Tissue sections (5 m) were prepared and transferred into 4% PBS-buffered formalin. Apoptosis was detected by staining cell nuclei with DNA strand breaks (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling [TUNEL] technology) using the In Situ Cell Death Detection Kit, Fluorescein (Roche), according to the manufacturer's instructions. Counterstaining and further procedure was performed as described above.
Data Analysis. All graphs show both single and median values from at least three independent experiments. Histological images show representative results. Data were analyzed by Mann-Whitney U test using SPSS software, with P Ͻ 0.05 considered significant. Next, we asked whether other Bcl-2 family members might be regulated in hepatocytes to compensate for the loss of Mcl-1 expression. Expression of Bcl-x L , Bid, Bax, and Bak, however, were not altered in liver lysates of Mcl-1 flox/flox -AlbCre mice (Supporting Fig. 1 ).
Results
Deletion of
Basal Liver Damage and Hepatic Fibrosis in Mcl-1 flox/flox -AlbCre Mice. We analyzed the effect of a loss of Mcl-1 expression for liver homeostasis. Interestingly, livers of Mcl-1 flox/flox -AlbCre mice appeared much smaller, and liver weight was profoundly reduced (64%-78% compared to control littermates, P Ͻ 0.001; Fig. 2A,B) . Body weight, however, was only slightly decreased ( Fig.  2A) . Furthermore, aspartate and alanine aminotransferase (AST and ALT) values, which are indicators of hepatocyte injury, were highly increased in these mice. Eight-weekold Mcl-1 flox/flox -AlbCre mice show a 7.6-fold increase in serum ALT levels (median: 280 U/L versus 40 U/L in control; P Ͻ 0.001) and a 5.7-fold increase in serum AST levels (median: 340 U/L versus 80 U/L in control; P Ͻ 0.001; Fig. 2C ). We also analyzed 4-week-old animals and again found a significant increase in serum aminotransferase levels (Fig. 2C) . Interestingly, AST and ALT levels were only slightly, yet still significantly, enhanced in 4-month-old animals (Fig. 2C ). In addition, we determined serum bilirubin values. There was no increase in bilirubin values in Mcl-1 flox/flox -AlbCre mice in the age of 8 weeks to 4 months, demonstrating that liver function was not impaired (data not shown).
Because Mcl-1 flox/flox -AlbCre mice reveal a basal liver damage, we asked whether this was due to spontaneous induction of apoptosis in hepatocytes. Therefore, we analyzed liver histology and stained liver sections of 4-weekold mice for active caspase-3 as a marker for the execution phase of apoptosis. Among Mcl-1 Ϫ/Ϫ hepatocytes, 1%-3% of cells were stained positive for active caspase-3. In contrast, control liver sections revealed hardly any or no caspase-3 positive hepatocytes (Fig. 3A) . To further validate this result, we also determined caspase-3 activity fluorometrically in liver lysates. Again, we found that caspase-3 activity was significantly enhanced in Mcl-1 Ϫ/Ϫ hepatocytes (Fig. 3B) . Furthermore, we analyzed DNA strand breaks to determine apoptosis rates. TUNEL assays revealed that five-fold more hepatocytes were positive for DNA strand breaks in Mcl-1 Ϫ/Ϫ livers compared to controls (P Ͻ 0.001; Fig. 3C ).
Next, we tested whether reduced liver mass in Mcl-1 flox/floxAlbCre mice is due to increased apoptosis rates or could also be caused by reduced proliferation of hepatocytes. To determine proliferation of Mcl-1 Ϫ/Ϫ hepatocytes, 4-week-old mice received BrdU in the drinking water for 60 hours. The amount of BrdU-positive nuclei was about 2.5-fold increased in Mcl-1 Ϫ/Ϫ hepatocytes compared to controls (17.5 versus 7%, P Ͻ 0.01; Fig. 4B ). Furthermore, we analyzed Ki67 expression, another marker for cell proliferation. Again, expression was profoundly increased in Mcl-1 Ϫ/Ϫ hepatocytes compared to controls (Fig. 4A) . Therefore, we conclude that the proliferation rate of Mcl-1 Ϫ/Ϫ hepatocytes is enhanced, presumably to partially compensate for the loss of hepatocytes due to apoptosis.
Then, we analyzed IL-6 and TNF expression in liver lysates of 16-week-old mice, to determine if the increase in apoptosis induction in Mcl-1 Ϫ/Ϫ hepatocytes leads to an inflammatory response. We could, however, observe no difference in IL-6 or TNF mRNA expression (data not shown). Next, we asked whether hepatic fibrosis occurs as a response to chronically increased apoptosis rates in Mcl-1 Ϫ/Ϫ livers. Therefore, we analyzed mRNA expression of collagen-1. Interestingly, collagen-1 expression was significantly enhanced in Mcl-1 Ϫ/Ϫ livers, indicating fibrosis induction (P Ͻ 0.01; Fig. 5A ). In addition, we stained Mcl-1 Ϫ/Ϫ liver sections with Sirius Red. Mcl-1 Ϫ/Ϫ mice revealed a mild degree of pericellular fibrosis at the age of 8 weeks, and even more at the age of 16 weeks, which was not observable in control littermates (Fig. 5B) .
Effect of Mcl-1 Deletion on CD95-Mediated or T
Cell-Mediated Liver Damage. CD95-mediated apoptosis of hepatoctytes contributes to the pathophysiology of various liver diseases. 18 Hepatocytes constitutively express CD95, and the liver is highly susceptible to CD95-induced apoptosis. 18, 19 To analyze the effect of Mcl-1 deletion on CD95 triggering on hepatocytes, we treated mice with the agonistic CD95-antibody Jo2. After Jo2 administration, 8-week-old Mcl-1 Ϫ/Ϫ mice had significantly elevated serum AST and ALT levels compared to control (AST: four-fold; ALT: nine-fold, P Ͻ 0.001; Fig.  6A ). Histology, immunohistochemical staining for active caspase-3, and analysis of caspase-3 activity in total liver lysates revealed that Mcl-1 Ϫ/Ϫ livers had both enhanced apoptosis levels and more severe architectural damage after Jo2-treatment (Fig. 6C,D,E) . Additionally, we treated older animals, which had only slightly enhanced basal aminotransferase levels (Fig. 2C) , with Jo2. Again, Mcl-1 flox/flox -AlbCre mice had significantly increased serum aminotransferase levels after Jo2-administration compared to control (P Ͻ 0.05; Fig. 6B ).
ConA-induced hepatitis is frequently used as a model for autoimmune liver disease and is dependent on T cell activity as well as CD95 signaling. 20, 21 We tested whether Mcl-1 deletion in hepatocytes influences T cell-mediated Total liver lysates were analyzed for caspase-3 activity. (E) Apoptosis rate and architectural damage were analyzed within hematoxylin/eosinstained sections and were clustered into four groups (0: no, 1: low, 2: moderate, 3: high apoptosis rate/architectural damage). * P Ͻ 0.05; ** P Ͻ 0.01; *** P Ͻ 0.001. RLU: relative light units.
liver injury in vivo. Eight-week-old mice were injected with 25 mg/kg body weight ConA into the tail vein. Mcl-1 Ϫ/Ϫ mice showed an increased liver damage after ConA treatment compared to control (AST: three-fold increase; ALT: six-fold increase; P Ͻ 0.05; Fig. 7) . We conclude that Mcl-1 deletion renders hepatocytes more susceptible to apoptosis stimuli, e.g., death receptor ligands and activated T cells.
Discussion
The aim of this study was to investigate the role of Mcl-1 for liver cell homeostasis and susceptibility of hepatocytes to apoptosis stimuli. Our results clearly demonstrate that Mcl-1 is an important antiapoptotic factor in the liver and contributes to hepatocyte survival, e.g., after death receptor activation.
Mcl-1 was first described in the human myeloid leukemia cell line ML-1, where it is induced early during phorbol ester-induced differentiation. 22 Further studies revealed that Mcl-1 is promoting viability rather than proliferation. In a vast number of cell types, transformed or untransformed, and after diverse stress or growth signals, Mcl-1 expression is rapidly induced and rescues cells from apoptosis induction. By contrast, Mcl-1 degradation is a prerequisite for cells to die. 23 Therefore, Mcl-1 expression is crucial in developing and differentiating cells, and in cells facing constant stress signals (like cancer cells). Mouse models revealed that Mcl-1 expression is crucial for embryonal development, 5 and for the viability of hematopoietic (stem) cells. 6, 7, 11 So far, little is known about the importance of Mcl-1 in fully differentiated liver cells. We have recently shown that Mcl-1 is induced by growth factors in primary human hepatocytes and contributes to the survival of primary human hepatocytes and hepatocellular carcinoma cells in vitro. 9, 12, 17 Thus, we hypothesized that Mcl-1 might also be a crucial factor for liver cell homeostasis in vivo. Therefore, we generated a hepatocyte-specific Mcl-1 knockout mouse. By mating Mcl-1 flox/flox mice with mice expressing the Cre-recombinase under the control of an albumin promoter, we obtained mice which still express Mcl-1 in hepatocytes at the time of birth. Deletion of the floxed DNA in this system is hepatocyte-specific. 24 However, a complete recombination of the floxed alleles takes up to 8 weeks. 14 7 Loss of Mcl-1 expression in hepatocytes of Mcl-1 flox/floxAlbCre mice was not compensated by an increase of Bcl-x L expression. Bcl-x L is another antiapoptotic protein of the Bcl-2 family prominently expressed in the liver. A conditional knockout of Bcl-x L in hepatocytes results in spontaneous hepatocyte apoptosis and development of liver fibrosis. 25 These studies have also shown that a deletion of Bcl-x L does not lead to an induction of Mcl-1. Therefore, despite similar functions and sequence homology, a loss of one of these proteins is not compensated by the induction of the other. In addition, expression of the proapoptotic Bcl-2 family proteins Bak and Bax was also not altered in hepatocytes lacking Mcl-1. In our model, deletion of Mcl-1 expression in hepatocytes caused a profound increase in hepatocyte apoptosis rate, and a decrease in liver size. Under physiologic conditions, liver size is highly regulated. Following a two-thirds hepatectomy in wild-type mice, liver mass normalizes after about 10 days. 26 In Mcl-1 flox/flox -AlbCre mice, we observed an enhanced proliferation rate of hepatocytes. However, this was not sufficient to compensate for apoptosis induction in the liver. As a marker of liver cell damage, AST and ALT serum levels were also drastically increased in Mcl-1 flox/flox -AlbCre mice. Interestingly, aminotransferase levels were higher in younger Mcl-1 flox/flox -AlbCre animals. In 16-week-old animals, aminotransferase levels were still higher than in control mice, yet not as high as in 4-weekold to 8-week-old mice.
Under physiologic conditions, enhanced apoptosis induction in the liver can cause an inflammatory response. 27 However, in our model, no increase of IL-6 and TNF expression was observed in Mcl-1 Ϫ/Ϫ livers. Progressive hepatic fibrosis is the main cause of organ failure in chronic liver diseases of different etiology. In Mcl-1 Ϫ/Ϫ livers, pericellular collagen deposition as a marker of fibrogenesis was observed, already at the age of 8 weeks. In parallel, bilirubin levels remained normal indicating that liver function was not impaired to a significant extent, at least not within the time frame analyzed.
Our data support the finding that Mcl-1 expression is a prerequisite for cell viability, but not for proliferation. 28 The proliferation rate of Mcl-1 Ϫ/Ϫ hepatocytes was enhanced. In contrary, hepatocyte viability in Mcl-1 Ϫ/Ϫ livers was decreased due to apoptosis induction.
Besides its importance for cell viability during growth and differentiation, Mcl-1 is also important for cell viability after stress or apoptosis signals. To demonstrate this, we analyzed the effect of Mcl-1 deletion on hepatocyte apoptosis after death receptor triggering. The death receptor CD95 is constitutively expressed on hepatocytes. Therefore, the liver is highly susceptible to activation of CD95. 19 Mice injected with agonistic CD95 antibodies die within a few hours upon injection due to liver failure. 29 Importantly, hepatocellular CD95 expression is increased in different acute and chronic liver diseases. 18 For example, CD95-induced apoptosis is a key mechanism in the pathophysiology of acute liver failure. 30 In our study, a deletion of Mcl-1 caused an increase in hepatocellular damage after administration of the agonistic CD95-antibody Jo2. This was reflected by increased AST and ALT levels, enhanced caspase-3 activation, and increased architectural damage in liver tissue. Higher susceptibility of Mcl-1 flox/flox -AlbCre mice toward CD95-triggering could also be observed in older mice, which show only slightly enhanced basal aminotransferase levels compared to controls. Therefore, we conclude that this effect was actually dependent on Mcl-1 deletion and not or only in part due to basal liver damage in these animals. Our results are in line with studies which have shown that Mcl-1 transgenic mice are more resistant toward acute liver failure induced by Jo2. 13 Furthermore, hepatocyte growth factor, an inducer of Mcl-1 expression in hepatocytes, 12 protects mice from Jo2-induced liver damage. 31 In contrast, a knockout of Bcl-x L in hepatocytes does not affect CD95-mediated apoptosis. 25 Furthermore, Mcl-1 flox/flox -AlbCre mice were more susceptible to T cell-mediated liver damage. Administration of ConA is a well-established in vivo model for T cell-mediated hepatitis. 21 Because activation of CD95 is also involved in T cell-mediated hepatitis, our results may be at least in part explained by the increased susceptibility of Mcl-1 Ϫ/Ϫ hepatocytes toward CD95 triggering.
In contrast, Mcl-1 deletion in hepatocytes did not influence the degree of liver damage after carbon tetrachloride (CCl 4 ) administration (Supporting Information). CCl 4 is hepatotoxic, leading to a chronic liver injury and fibrogenesis. 32 In our study, the extent of fibrosis after CCl 4 exposure was not different in Mcl-1 Ϫ/Ϫ animals compared to control littermates. This might be explained by the limited time of CCl 4 exposure (5 weeks).
Interestingly, in previous studies we did not observe any effect of postnatally induced Mcl-1 deletion on liver morphology. 6 Crossing of Mcl-1 flox/null mice with MxCre mice results in a rapid deletion of Mcl-1 in bone marrow cells and hepatocytes after intraperitoneal administration of polyinosinic-polycytidylic acid in adult mice. In these mice, no liver damage was histologically detectable within 14 days after induction of Mcl-1 deletion. In the present model, recombination of the floxed Mcl-1 alleles starts already during embryogenesis and liver morphology is significantly altered. Thus, we conclude that expression of Mcl-1 is very important for proliferating hepatocytes in the liver of younger animals. This is in line with previous studies showing that Mcl-1 is important during differentiation. 33 In the adult mouse, when the liver has only minor renewing activity, Mcl-1 expression is of minor importance as long as hepatocytes are not exposed to apoptosis stimuli.
In summary, the present study shows that Mcl-1 expression is crucial for hepatocyte survival in vivo. A deletion of Mcl-1 in hepatocytes causes activation of apoptosis, resulting in chronic liver damage and fibrogenesis. Furthermore, Mcl-1 deletion renders hepatocytes more susceptible to death receptor-induced apoptosis. Therefore, we conclude that Mcl-1 is an important survival factor for hepatocytes. assistance, and Cornelius Fritsch for critically reading the manuscript.
